CG-0161

N/A

Report date: 2023/04/07 16:11:16

Base Information

Drug NameCG-0161

Drug Alias NameCG-0161

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody

Mechanisms of ActionImmunomodulatorsAntibody-dependent cell-mediated cytotoxicity (ADCC) effectsCytotoxic T-Lymphocyte-Associated Antigen 4 inhibitors

TargetsCytotoxic T-Lymphocyte-Associated Antigen 4

Therapy Area/IndicationsNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesCG Oncolgy Inc

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesN/A

Active IndicationsNeoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A